UTime Limited

WTO

Market cap $5.08M

SHENZHEN, China, Feb. 06, 2026 (GLOBE NEWSWIRE) -- UTime Limited (Nasdaq: WTO) today announced that its share consolidation (“Share Consolidation”) involving the consolidation of every five (5) Class A ordinary shares, with a par value of US$0.10 per share, into one (1) class A ordinary share with a par value of US$0.50 per share, will take effect at 8:00 a.m. Eastern Time on February 17, 2026. The Company's Class A Ordinary shares will open for trading on the Nasdaq Capital Market on February 17, 2026, on a post-split basis, under the existing ticker symbol “WTO,” with a new CUSIP number of G9411M140.

SHENZHEN, China, Feb. 03, 2026 (GLOBE NEWSWIRE) -- UTime Limited (Nasdaq: WTO), a global technology company engaged in the design, development, and manufacturing of mobile devices and smart hardware products, today announced that its Shenzhen-based subsidiary, Shenzhen Liandai Technology Co., Ltd. (“Shenzhen Liandai”), has entered into a strategic Intentional Order Cooperation Agreement (the “Cooperation Agreement”) with Shenzhen Yunwei Digital Technology Co., Ltd. (“Shenzhen Yunwei Digital”) for the potential supply of 500,000 units of smart servers, representing an estimated contract value of approximately $50 million.

SHENZHEN, China, Dec. 31, 2025 (GLOBE NEWSWIRE) -- UTime Limited (Nasdaq: WTO), a global technology company engaged in the design and development of mobile devices today announced a major commercial breakthrough. UTime's Hong Kong subsidiary, UTime Technology (HK) Company Limited, has officially signed a smart health device procurement agreement worth nearly $10 million USD with Tumu Vertex LLC, a Denver-based entity, marking a crucial step in UTime's strategic deployment in the North American medical-grade smart wearable market.

SHENZHEN, China, Nov. 12, 2025 (GLOBE NEWSWIRE) -- UTime Limited (Nasdaq: WTO) today announced that it will implement a reverse stock split of its common shares at a ratio of 1-for-100, effective 12:01 a.m. Eastern Time on November 21, 2025.

SHENZHEN, China, Nov. 05, 2025 (GLOBE NEWSWIRE) -- UTime Limited (Nasdaq: WTO) today announced that it is actively promoting its smart wearable devices to more international markets through its existing global distribution channels and partner network.

SHENZHEN, China, Nov. 03, 2025 (GLOBE NEWSWIRE) -- UTime Limited (Nasdaq: WTO) today outlined its ongoing exploration in the field of health data analysis, particularly the potential application of artificial intelligence (AI) technologies.

SHENZHEN, China, Oct. 30, 2025 (GLOBE NEWSWIRE) -- UTime Limited (Nasdaq: WTO) today released its smart ring product. Utilizing the advantage of unnoticeable wear, the product aims to provide users with nighttime and long-term continuous health data monitoring.

SHENZHEN, China, Oct. 28, 2025 (GLOBE NEWSWIRE) -- UTime Limited (Nasdaq: WTO), a global technology company engaged in the design and development of mobile devices, today announced the launch of a smartwatch with integrated blood pressure monitoring functionality, further expanding its product portfolio in the health technology sector.

New York, Oct. 17, 2025 (GLOBE NEWSWIRE) -- Univest Securities, LLC (“Univest”), a member of FINRA and SIPC, and a full-service investment bank and securities broker-dealer firm based in New York, today announced the closing of a registered direct offering (the “Offering”) of approximately $25 million for its client UTime Limited (NASDAQ: WTO)(the “Company” or “UTime”), a consumer electronics and mobile device manufacturer specializing in the design, production, and sale of smartphones, feature phones, and related accessories under both OEM/ODM and self-owned brands.

Shenzhen, China, Oct. 16, 2025 (GLOBE NEWSWIRE) -- UTime Limited (Nasdaq: WTO) (the “Company”), a consumer electronics and mobile device manufacturer specializing in the design, production, and sale of smartphones, feature phones, and related accessories under both OEM/ODM and self-owned brands, today announced that it has entered into a definitive securities purchase agreement with five institutional investors for the purchase and sale of an aggregate of 22,727,275 units (each, a “Unit”), consisting of one class A ordinary share of the Company, par value $0.001 per share (each, an “Class A Ordinary Share”) and one Series A warrant (each, a “Warrant”), at a purchase price of $1.10 per Unit in a registered direct offering.